John Joyoprayitno
Vorstandsvorsitzender bei Alafair Biosciences, Inc.
Ursprung des Netzwerks ersten Grades von John Joyoprayitno
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Alafair Biosciences, Inc.
 Alafair Biosciences, Inc. Medical SpecialtiesHealth Technology Alafair Biosciences, Inc. operates as a medical device company. It develops novel suite of products based on a non-cell adhesive hydrogel technology that protects and manages advanced wound healing. The firm addresses problems of wound healing and scar prevention with natural, animal-free biopolymer based products that are biocompatible, bioresorbable and hydrate injured tissues throughout healing. The company was founded by Daniel L. Peterson, John D. Joyoprayitno and Sarah Mayes in 2011 and is headquartered in Austin, TX.
5
| Holding Company | Medical Specialties | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John Joyoprayitno
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Michigan | College/University | Undergraduate Degree Graduate Degree | |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Medical Specialties | Director of Finance/CFO | |
| University of Colorado Health Sciences Center | College/University | Doctorate Degree | |
ATP Management Co LLC
 ATP Management Co LLC Investment ManagersFinance ATP Management Co LLC (ATP Fund) is a venture capital firm founded in 2014. The firm is headquartered in Austin, Texas. | Investment Managers | Private Equity Investor | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
Telephus Medical LLC
 Telephus Medical LLC Miscellaneous Commercial ServicesCommercial Services Telephus Medical LLC is a biotechnology company that develops immunotherapy products. The private company is based in Rochester, NY and was founded in 2012 by Mark Benedyk. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
Accel-Rx
 Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Financial Conglomerates | Director/Board Member | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Rila Partners LLC | Corporate Officer/Principal | ||
| The Rockefeller University | College/University | Doctorate Degree | |
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| Brackenridge Hospital | Human Resources Officer | ||
| Princeton University | College/University | Undergraduate Degree | |
| ORTHOFIX MEDICAL INC. | Medical Specialties | Director/Board Member | |
| ANIKA THERAPEUTICS, INC. | Medical Specialties | Chairman | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| R1 RCM INC. | Miscellaneous Commercial Services | Director/Board Member | |
| The University of Michigan Law School | College/University | Graduate Degree | |
| SEAE HLDG | Information Technology Services | Director/Board Member | |
New Deal Technology SAS
 New Deal Technology SAS Medical SpecialtiesHealth Technology New Deal Technology SAS develops and manufactures specialty implants and instruments for foot and ankle surgery. It offers adjustment guides, ankle prosthesis, fracture plates, compression pins, compression screws, compression staples and flat foot implants. The company was founded in 1997 by Fourcault Eric and is headquartered in Lyon, France. | Medical Specialties | Chairman | |
| Emory University | College/University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 22 |
| Kanada | 3 |
| Schweden | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 11 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 13 |
| Independent Dir/Board Member | 6 |
| Doctorate Degree | 3 |
| Undergraduate Degree | 3 |
| Chairman | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John Henneman | 13 |
| Mark Benedyk | 9 |
| Daniel Peterson | 3 |
| Sarah Mayes | 3 |
| Kyle Cox | 3 |
- Börse
- Insiders
- John Joyoprayitno
- Unternehmensverbindungen
